HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

copper 1,4,8,11- - tetraazacyclotetradecane- N,N',N'',N'''- tetraacetic acid-octreotide

a PET imaging agent

Also Known As:

64Cu-TETA-octreotide; Cu-TETA-octreotide

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Organometallic Compounds: 64
  - copper 1,4,8,11--tetraazacyclotetradecane-N,N',N'',N'''-tetraacetic acid-octreotide: 3
Polycyclic Compounds: 6
- Macrocyclic Compounds: 15
  - Cyclic Peptides: 530
    - Octreotide: 5228
      - copper 1,4,8,11--tetraazacyclotetradecane-N,N',N'',N'''-tetraacetic acid-octreotide: 3
Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Cyclic Peptides: 530
    - Octreotide: 5228
      - copper 1,4,8,11--tetraazacyclotetradecane-N,N',N'',N'''-tetraacetic acid-octreotide: 3

Experts

1.	Anderson, C J: 1 article (02/2001)
2.	Bass, L A: 1 article (02/2001)
3.	Cutler, P D: 1 article (02/2001)
4.	Dehdashti, F: 1 article (02/2001)
5.	Laforest, R: 1 article (02/2001)
6.	Lewis, J S: 1 article (02/2001)
7.	McCarthy, D W: 1 article (02/2001)
8.	Schwarz, S W: 1 article (02/2001)

Related Diseases

1.	Neoplasms (Cancer) 10/01/1999 - "Also, tumor uptake of 64Cu-TETA-octreotide at 4 h was not significantly different when administered either 2 or 4 days after injection of AdSSTr2 (P = 0.076). " 10/01/1999 - "with 64Cu-TETA-octreotide showed a median uptake of 24.3% ID/g in tumor at 4 h postinjection compared with 4.9% ID/g at 18 h after injection. " 10/01/1999 - "64Cu-TETA-octreotide should be useful for targeted radiotherapy against tumors that are genetically induced to express high levels of SSTr. " 11/01/1999 - "It has been demonstrated previously that the somatostatin analogue 64Cu-TETA-octreotide (64Cu-TETA-OC, where TETA is 1,4,8,11-tetraazacyclotetradecane-N,N',N",N"'-tetraacetic acid) significantly inhibited the growth of somatostatin receptor-positive CA20948 rat pancreatic tumors in Lewis rats (C. "
2.	Neuroendocrine Tumors (Neuroendocrine Tumor) 02/01/2001 - "64Cu-TETA-octreotide as a PET imaging agent for patients with neuroendocrine tumors."

Related Drugs and Biologics

1.	Somatostatin Receptors (Somatostatin Receptor)
2.	Somatostatin (Somatotropin Release-Inhibiting Factor)
3.	Acids

Related Therapies and Procedures

1.	Radiotherapy